SOUTH ORANGE, NJ, Aug. 01, 2024 (GLOBE NEWSWIRE) — Nephros, Inc. (Nasdaq: NEPH), a leading water technology company providing filtration solutions for both healthcare and commercial markets, today announced that it will file its second-quarter financial results on Thursday, August 8, 2024 after market close and will host a conference call that same day at 4:30pm ET.
Participants may dial into the call as follows:
Domestic access: 1 (844) 808-7106
International access: 1 (412) 317-5285
Upon joining, please ask to be joined into the Nephros conference call.
An audio archive of the call will be available shortly after the call on the Nephros Investor Relations page.
Alternatively, a replay of the call may be accessed until August 15, 2024 at 1 (877) 344-7529 or
1 (412) 317-0088 for international callers and entering replay access code: 5799241.
About Nephros
Nephros is committed to improving the human relationship with water through leading, accessible technology. We provide innovative water filtration products and services, along with water-quality education, as part of an integrated approach to water safety. Nephros goods serve the needs of customers within healthcare and commercial markets, offering both proactive and emergency solutions for water management.
For more information about Nephros, please visit us at nephros.com.
Investor Relations Contacts:
Kirin Smith, President
PCG Advisory, Inc.
(646) 823-8656
ksmith@pcgadvisory.com
Robert Banks, CEO
Nephros, Inc.
(201) 343-5202 x110
robert.banks@nephros.com
TAMPA, FL / ACCESS Newswire / December 30, 2025 / CTT Pharmaceutical Holdings, Inc. (OTCQB:CTTH)…
The newest member of the Active family blends new design, expanded storage, and longer battery…
REDDING, Calif., Dec. 29, 2025 /PRNewswire/ -- Docs Medical Group, Inc. dba Pulse Urgent Care…
AUSTIN, TEXAS / ACCESS Newswire / December 29, 2025 / Interactive Strength Inc. (Nasdaq:TRNR) ("TRNR"…
FDA Law-Not Hemp, Marijuana Politics-Will Decide the Future of Cannabinoid Medicine.Why "Full-Spectrum CBD" Narratives Are…
PLEASANTON, Calif., Dec. 29, 2025 /PRNewswire/ -- 10x Genomics, Inc. (Nasdaq: TXG), a leader in single cell…